Inventor
GANGULY ASHIT K
US83 patents
⚠️ This page may combine multiple inventors who share the name “GANGULY ASHIT K”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
SCHERING CORP
46 patentsUS5089496AFeb 18, 1992
Benzo[5,6]cycloheptapyridine compounds, compositions and method of treating allergies
SCHERING CORP138 citations99
US6838475B2Jan 4, 2005
Imidazolidinones as NS3-serine protease inhibitors of hepatitis C virus
SCHERING CORP121 citations97
US6800434B2Oct 5, 2004
Peptides as NS3-serine protease inhibitors of hepatitis C virus
SCHERING CORP89 citations97
US6403564B1Jun 11, 2002
Ribavirin-interferon alfa combination therapy for eradicating detectable HCV-RNA in patients having chronic hepatitis C infection
SCHERING CORP122 citations97
US6277830B1Aug 21, 2001
5′-amino acid esters of ribavirin and the use of same to treat hepatitis C with interferon
SCHERING CORP120 citations97
US5750532AMay 12, 1998
Pharmaceutically active compounds
SCHERING CORP68 citations96
US5661151AAug 26, 1997
Tetrahydrofuran antifungals
SCHERING CORP69 citations96
US5459144AOct 17, 1995
Pharmaceutically active compounds
SCHERING CORP64 citations96
US5272167ADec 21, 1993
Pharmaceutically active compounds
SCHERING CORP104 citations96
US4851423AJul 25, 1989
Pharmaceutically active compounds
SCHERING CORP86 citations96
US4826853AMay 2, 1989
6,11-Dihydro-11-(N-substituted-4-piperidylidene)-5H-benzo(5,6)cyclohepta(1,2-B)pyridines and compositions and methods of use
SCHERING CORP90 citations96
US6914122B2Jul 5, 2005
Macrocyclic NS-3 serine protease inhibitors of hepatitis C virus comprising alkyl and aryl alanine P2 moieties
SCHERING CORP89 citations95
US4076711AFeb 28, 1978
Triazolo [4,5-d]-pyrimidines
SCHERING CORP55 citations95
US5116840AMay 26, 1992
Polycyclic quinoline, naphthyridine and pyrazinopyridine derivatives
SCHERING CORP45 citations94
US5714490AFeb 3, 1998
Tetrahydrofuran antifungals
SCHERING CORP37 citations93
US5693626ADec 2, 1997
Tetrahydrofuran antifungals
SCHERING CORP24 citations93
US5039676AAug 13, 1991
Tri- and tetra-substituted-oxetanes and tetrahydrofurans and intermediates thereof
SCHERING CORP54 citations93
US5403937AApr 4, 1995
Process for preparing intermediates for the synthesis of antifungal agents
SCHERING CORP21 citations92
US5104876AApr 14, 1992
Benzopyrido piperidine, piperidylidene and piperazine compounds, compositions, methods of manufacture and methods of use
SCHERING CORP39 citations92
US5034531AJul 23, 1991
Fused polycyclic pyranyl compounds as antiviral agents
SCHERING CORP37 citations92
US4530793AJul 23, 1985
Processes for the production of penems
SCHERING CORP30 citations92
US4443373AApr 17, 1984
Process for the production of antibiotic penems
SCHERING CORP27 citations92
US5446069AAug 29, 1995
Benzoalkano compounds and their use for tracting hyperproliferative diseases
SCHERING CORP16 citations82
US5439916AAug 8, 1995
Polycyclic quinoline, naphthyridine and pyrazinopyridine derivatives
SCHERING CORP19 citations81
US5126352AJun 30, 1992
Polycyclic quinoline, naphthyridine and pyrazinopyridine derivatives
SCHERING CORP19 citations81
US5710154AJan 20, 1998
Tetrahydrofuran antifungals
SCHERING CORP13 citations74
US5703079ADec 30, 1997
Tetrahydrofuran antifungals
SCHERING CORP16 citations74
US5703236ADec 30, 1997
Tetrahydrofuran antifungals
SCHERING CORP11 citations74
US5438062AAug 1, 1995
Benzo(5,6)cycloheptapyridines, compositions and methods of use
SCHERING CORP8 citations74
US4999428AMar 12, 1991
Process for preparing cyclopentyl purine derivatives
SCHERING CORP12 citations74
US4614738ASep 30, 1986
2-(N-heterocycloaliphaticthio)penems
SCHERING CORP7 citations74
US4584133AApr 22, 1986
Process for the production of penems
SCHERING CORP12 citations74
US4503064AMar 5, 1985
Oxime substituted penems
SCHERING CORP6 citations74
US4436729AMar 13, 1984
23-Demycinosyltylosin compounds, pharmaceutical compositions and method of use
SCHERING CORP9 citations74
US4435412AMar 6, 1984
5R,6S,8R-2-(1-Methyl-2-imidazolylmethylthio)-6-(1-hydroxyethyl)penem-3-carboxylic acid
SCHERING CORP11 citations74
US4411906AOct 25, 1983
(5R,6S,8R)-6-(1-Hydroxyethyl)-2-(2-fluoroethylthio)-penem-3-carboxylates
SCHERING CORP6 citations74
US4279896AJul 21, 1981
Novel 20-imino macrolide antibacterial agents
SCHERING CORP14 citations74
US7115578B2Oct 3, 2006
Ribavirin-interferon alfa combination therapy for eradicating detectable HCV-RNA in patients having chronic hepatitis C infection
SCHERING CORP8 citations73
US5665726ASep 9, 1997
Benzo[5,6]cycloheptapyridines, compositions and methods of use
SCHERING CORP7 citations73
US4767748AJul 30, 1988
Substituted oligosaccharide antibodies
SCHERING CORP8 citations73
US4622314ANov 11, 1986
Substituted oligosaccharide antibiotics
SCHERING CORP8 citations73
US4559333ADec 17, 1985
Hydrazone substituted penems
SCHERING CORP7 citations73
US4129720ADec 12, 1978
Aminoeverninomicin and derivatives thereof
SCHERING CORP6 citations73
US4006225AFeb 1, 1977
Method of using reduction products of everninomicins as antibacterial agents and pharmaceutical compositions useful therefor
SCHERING CORP7 citations73
US3975372AAug 17, 1976
Preparation of 12,13-desepoxy-12,13-dehydrorosamicin
SCHERING CORP12 citations73
US5449680ASep 12, 1995
2,2 disubstituted glycerol and glycerol-like compounds, compositions and methods of use
SCHERING CORP10 citations72
DENDREON CORP
3 patentsUS7012066B2Mar 14, 2006
Peptides as NS3-serine protease inhibitors of hepatitis C virus
DENDREON CORP176 citations98
US7244721B2Jul 17, 2007
Peptides as NS3-serine protease inhibitors of hepatitis C virus
DENDREON CORP80 citations97
US7169760B2Jan 30, 2007
Peptides as NS3-serine protease inhibitors of hepatitis C virus
DENDREON CORP88 citations97
SAKSENA ANIL K
1 patentShowing the top 50 of 83 patents by PatentIndex Score.